BioSight

BioSight is a leading biopharmaceutical company dedicated to the development of innovative peptide-based targeted drugs. With a focus on addressing unmet clinical needs, BioSight specializes in cancer-targeted chemotherapy, offering advanced solutions for patients worldwide.

Located at Hanapach 34, Karmiel, 21653, IL, BioSight leverages its extensive expertise in peptide synthesis to provide custom R&D services. Serving both academic institutions and the biotech industry, BioSight is committed to advancing the field of peptide drug development through cutting-edge research and collaborative partnerships.

Since its founding in 1999, BioSight has been at the forefront of biotechnology, driving progress in targeted therapeutics. Information about BioSight is being completed with the support of the company’s management, ensuring accuracy and comprehensiveness. We invite the manager of BioSight to create a customized and exclusive company showcase and product listing on our platform to further enhance their visibility and commercial development.